Advertisement
Screener

Glucotrack, Inc. (GCTK) Right-of-Use Asset Obtained in Exchange for Operating Lease Liability

Glucotrack, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability

Glucotrack, Inc. (GCTK) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $79.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2026-05-14.

Financial Statements › Notes › Leases

us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-05-14

  • Glucotrack, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-03-31 was $79.00K, a 0.00% change year-over-year.
  • Glucotrack, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-12-31 was $0.00.
  • Glucotrack, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-09-30 was $0.00.
  • Glucotrack, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-06-30 was $0.00.
  • Glucotrack, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $79.00K.
Period endRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 monthRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 monthRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 monthRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month
2025-03-31$79.00K
10-Q · filed 2026-05-14
$79.00K
derived: sum of 2 quarters · filed 2026-05-14
$79.00K
derived: sum of 3 quarters · filed 2026-05-14
$79.00K
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
$0.00
derived: sum of 2 quarters · filed 2026-03-30
$0.00
derived: sum of 3 quarters · filed 2026-03-30
$79.00K
10-K · filed 2026-03-30
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$0.00
derived: sum of 2 quarters · filed 2025-11-13
$79.00K
10-Q · filed 2025-11-13
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$79.00K
10-Q · filed 2025-08-14
2024-03-31$79.00K
10-Q · filed 2025-05-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
ACCURAY INC (ARAY)United States$0.027B-0.63
PAVmed Inc. (PAVM)United States$0.031B-3.00
InspireMD, Inc. (NSPR)$0.033B
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
Modular Medical, Inc. (MODD)United States$0.018B-0.88
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
CERENOME, INC. (CNSY)United States$0.014B
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47